Stocks making the biggest moves at noon: Austal, St Barbara, Domain and more

These are the companies and sectors making headlines in afternoon trade.

Neuren Pharmaceuticals (ASX: NEU) – Shares rallied 5.2% after its US-based partner Acadia Pharmaceuticals entered into a definitive asset purchase agreement to sell the Rare Pediatric Disease Priority Review Voucher (PRV) for US$150 million. Under the license agreement between Neuren and Acadia, the company is entitled to receive one-third of the proceeds.

Austal (ASX: ASB) – Shares in the shipbuilder rallied 4.0% after Bell Potter upgraded its target price from Please review the below article and make sure all the sentences are gramatically correct and make sense. Let me know of any that don't. $3.15 to $3.75. "The anticipated EBIT growth in FY25 is early evidence that Austal’s underlying business is performing strongly and the company believes this signals the end of the transition period (from legacy to new shipbuilding programs) and the start of the execution phase," the report said. The analysts believe there is potential for further upside to the provided guidance based on the US$450 million US submarine module contract announced on 16 September 2024.

St Barbara (ASX: SBM) – Shares in the gold miner bounced 5.1% after Macquarie analysts upgraded the stock to Outperform with a 49 cent target price. "Following a 22% post-raise share price fall, SBM's capital raise metrics were almost identical to our prior estimate with SBM also retaining commentary around Simberi's development timeline," the analysts said. The company successfully raise $100 million on Tuesday at 38 cents a piece (17% discount) to accelerate the Simberi Sulphide Project with first gold targeted for 1Q28.

Elders (ASX: ELD) – Shares rallied 3.9% after receiving a small upgrade from Citi. The analysts raised their target price by 1.0% to $9.75.

Domain Holdings (ASX: DHG) – Shares down 5.3% to a fresh 6 week low after providing a first-quarter FY25 trading update at its AGM. The solid face value numbers may have missed market expectations. In the lead up to the quarterly, Citi analysts said "there is a sense of nervousness given the CEO departure announcement. We expect Domain to report stronger listings growth than REA, however we expect controllable yield to be negatively impacted by free listings coming back."

• Total revenue for 1Q25 (1 July to 30 September) up 8% year-on-year

• October new listings growth has continued to accelerate

• FY25 cost and EBITDA guidance maintained

• Margin expansion expected in FY25 and beyond

Stocks rallying on no news include: Brainchip (+9.5%), Zip (+7.1%), Appen (+5.8%) and Ora Banda Mining (+5.2%).